SHAREHOLDER ALERT: WeissLaw LLP Reminds THBR, GIX, ALXN and STPK Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 29, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and

would like to discuss our investigations or have any questions concerning

this notice or your rights or interests, please contact:

Joshua Rubin, Esq.

WeissLaw LLP

1500 Broadway, 16^th Floor

New York, NY  10036

(212) 682-3025

(888) 593-4771

stockinfo@weisslawllp.com 

Thunder Bridge Acquisition II Ltd. THBR

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Thunder Bridge Acquisition II Ltd. THBR in connection with the company's proposed merger with privately held indie Semiconductor.  Under the terms of the merger agreement, THBR will acquire indie Semiconductor through a reverse merger that will result in indie Semiconductor becoming a publicly traded company.  If you own THBR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/thbr/   

GigCapital2, Inc. GIX

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GigCapital2, Inc. GIX in connection with the company's proposed merger with privately held digital healthcare provider UpHealth Holdings, Inc. ("UpHealth") and privately held telemedicine provider Cloudbreak Health, LLC ("Cloudbreak").  GIX will combine with Uphealth and Cloudbreak via a reverse-merger to create a single publicly- traded digital healthcare company.  If you own GIX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://www.weisslawllp.com/gix/ 

Alexion Pharmaceuticals, Inc. ALXN

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alexion Pharmaceuticals, Inc. ALXN in connection with the proposed acquisition of the company by AstraZeneca PLC ("AstraZeneca").  Under the terms of the agreement, ALXN shareholders will receive $60.00 and 2.1243 AstraZeneca American Depositary Shares ("ADS") (each ADS representing one-half of one ordinary share of AstraZeneca) for each share of ALXN they hold.  If you own ALXN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/alxn/ 

Star Peak Energy Transition Corp. STPK

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Star Peak Energy Transition Corp. STPK in connection with the company's proposed merger with privately held Stem Inc. ("Stem").  Under the terms of the merger agreement, STPK will acquire Stem through a reverse merger that will result in Stem becoming a publicly traded company.  If you own STPK shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/stpk/    

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-thbr-gix-alxn-and-stpk-shareholders-about-its-ongoing-investigations-301218343.html

SOURCE WeissLaw LLP